LON:EKF

EKF Diagnostics Interim Earnings Results & Report

EKF Diagnostics logo
GBX 23.90 +0.20 (+0.84%)
As of 03:14 AM Eastern

EKF Diagnostics reported Interim earnings on September 16, 2025. The company reported EPS of GBX 0.43.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

EKF Diagnostics EPS Results

Actual EPS
GBX 0.43
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

EKF Diagnostics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

EKF Diagnostics Interim Earnings FAQ

EKF Diagnostics (LON:EKF) reported earnings of GBX 0.43 per share for Interim. The report was announced on Tuesday, September 16, 2025.

EKF Diagnostics Earnings Headlines

EKF Diagnostics : Connect with EKF at ASCP/CAP-ACP 2026
EKF Diagnostics : Connect with EKF Diagnostics at AABB 2026
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
EKF Diagnostics : Connect with EKF Diagnostics at EAHS Africa 2026
EKF Diagnostics Holdings Plc H1 Income Climbs
See More EKF Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like EKF Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on EKF Diagnostics and other key companies, straight to your email.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

View EKF Diagnostics Profile